Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia

被引:10
作者
Chang, Christopher Y. [1 ]
Chabot, Peter [1 ]
Thomas, James P. [1 ]
机构
[1] PLC, Warrenton, VA 20186 USA
关键词
D O I
10.1016/j.otohns.2007.01.035
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Objective evaluation of botulinum toxin A (BTX-A) dosing by determination of the statistical relationship between injection amount and duration of side effects and normal voice in adductor spasmodic dysphonia (SD) patients. From this information, to provide a rational guide to determine the initial and follow-up BTX-A amounts for injection. Study Design and Detting: Private laryngology clinic. Statistical analysis was performed on data obtained from 101 patients with SD. Results: Significant and predictable positive correlations were found between duration of side effects and duration of normal voice after BTX-A injection in patients with SD. Dose of BTX-A injected also appeared to have a significant positive correlation with duration of side effects, but a negative correlation with duration of normal voice. A trend toward more severe side effects was seen with larger doses of BTX-A injections. Conclusions and Significance: Increased understanding of the response of the human voice over time after BTX-A injection at various doses suggests new ideas to further increase clinical efficacy with the use of lower BTX-A doses. (C) 2007 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:894 / 899
页数:6
相关论文
共 19 条
  • [11] Effect of volume and concentration on the diffusion of botulinum exotoxin A
    Hsu, TSJ
    Dover, JS
    Arndt, KA
    [J]. ARCHIVES OF DERMATOLOGY, 2004, 140 (11) : 1351 - 1354
  • [12] Thyroplasty for adductor spasmodic dysphonia: Further experiences
    Isshiki, N
    Haji, T
    Yamamoto, Y
    Mahieu, HF
    [J]. LARYNGOSCOPE, 2001, 111 (04) : 615 - 621
  • [13] Treatment of adductor-type spasmodic dysphonia by surgical myectomy: A preliminary report
    Koufman, JA
    Rees, CJ
    Halum, SL
    Blalock, D
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2006, 115 (02) : 97 - 102
  • [14] Low- and high-dose botulinum toxin A treatment:: A retrospective analysis
    Sätilä, H
    Kotamäki, A
    Koivikko, M
    Autti-Rämö, I
    [J]. PEDIATRIC NEUROLOGY, 2006, 34 (04) : 285 - 290
  • [15] SHAARI CM, 1991, LARYNGOSCOPE, V101, P960
  • [16] QUANTIFYING HOW LOCATION AND DOSE OF BOTULINUM TOXIN INJECTIONS AFFECT MUSCLE PARALYSIS
    SHAARI, CM
    SANDERS, I
    [J]. MUSCLE & NERVE, 1993, 16 (09) : 964 - 969
  • [17] Sulica Lucian, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P543, DOI 10.1097/01.moo.0000145959.50513.5e
  • [18] Molecular targets of botulinum toxin at the mammalian neuromuscular junction
    Whelchel, DD
    Breluner, TM
    Brooks, PM
    Coffield, JA
    [J]. MOVEMENT DISORDERS, 2004, 19 : S7 - S16
  • [19] Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity
    Wyndaele, JJ
    Van Dromme, SA
    [J]. SPINAL CORD, 2002, 40 (11) : 599 - 600